Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

20%

Ph phase_1

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

4(80.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Other(2)

Detailed Status

unknown2

Terminated1

Completed1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 1

Trials by Phase

Phase 14 (80.0%)

N/A1 (20.0%)

Trials by Status

terminated120%

completed120%

not_yet_recruiting120%

unknown240%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis

NCT02975219

completedphase_1

Fluorescence Guided Surgery in Breast Cancer

NCT02583568

Clinical Trials (5)

Showing 5 of 5 trials

NCT06008522Not Applicable

Safety and Feasibility of Immuno-OCT

Not Yet Recruiting

NCT03925285Phase 1

Image Guided Surgery in Sinonasal Inverted Papilloma

Unknown

NCT02743975Phase 1

Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma

Terminated

NCT02975219Phase 1

Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis

Unknown

NCT02583568Phase 1

Fluorescence Guided Surgery in Breast Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5